Most discussion of the compound happens through the CagriSema lens, where the semaglutide component muddies how much credit amylin deserves
It is recommended that researchers follow appropriate dosing protocols based on study requirements
Possible Side Effects and Safety Considerations The most common side effects reported in Phase 2 trials are gastrointestinal, including nausea, vomiting, and diarrhoea
A decrease in free and total serum carnitine concentration, reduced pyruvate, and increased alanine and ammonia levels were observed in another cohort of patients diagnosed with ASD [71]
If you have been on Semaglutide or Tirzepatide for an extended period without seeing weight loss, it may be time to consult your healthcare provider
New safety signal: dysesthesia (abnormal skin sensations) in up to 21% of participants on the highest dose